Cathepsin D gene and the risk of Alzheimer's disease: A population-based study and meta-analysis

Neurobiology of Aging

Volumn 32, Issue 9, 2011, Pages 1607-1614

  Schuur, M ^a   Ikram, M A ^a,b   van Swieten, J C ^a   Isaacs, A ^a   Vergeer Drop, J M ^a   Hofman, A ^a   Oostra, B A ^a   Breteler, M M B ^a,b   Van Duijn, C M ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b University Medical Center ^*  (Netherlands)

Author keywords

Alzheimer's disease; Cathepsin D gene; Cohort study; Meta analysis; Population based

Indexed keywords

APOLIPOPROTEIN E4; CATHEPSIN D; GENOMIC DNA;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CATHEPSIN D GENE; COHORT ANALYSIS; CONTROLLED STUDY; EFFECT SIZE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CATHEPSIN D; COHORT STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79960123455     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.10.011     Document Type: Article

References (58)

1. Bagnoli S., Nacmias B., Tedde A., Guarnieri B.M., Cellini E., Ciantelli M., Petruzzi C., Bartoli A., Ortenzi L., Serio A., Sorbi S. Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 2002, 328:273-276.
2. Bertram L., Guenette S., Jones J., Keeney D., Mullin K., Crystal A., Basu S., Yhu S., Deng A., Rebeck G.W., Hyman B.T., Go R., McInnis M., Blacker D., Tanzi R. No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease. Ann. Neurol. 2001, 49:114-116.
3. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39:17-23. (Accessed on March 1st 2009).
4. Beyer K., Lao J.I., Latorre P., Ariza A. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease. Ann. N.Y. Acad. Sci. 2005, 1057:260-278.
5. Bhojak T.J., DeKosky S.T., Ganguli M., Kamboh M.I. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci. Lett. 2000, 288:21-24.
6. Blomqvist M.E., Reynolds C., Katzov H., Feuk L., Andreasen N., Bogdanovic N., Blennow K., Brookes A.J., Prince J.A. Towards compendia of negative genetic association studies: an example for Alzheimer disease. Hum. Genet. 2006, 119:29-37.
7. Campion D., Dumanchin C., Hannequin D., Dubois B., Belliard S., Puel M., Thomas-Anterion C., Michon A., Martin C., Charbonnier F., Raux G., Camuzat A., Penet C., Mesnage V., Martinez M., Clerget-Darpoux F., Brice A., Frebourg T. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 1999, 65:664-670.
8. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Bifaro L., Menga R., Santamato A., Seripa D., Pilotto A., Capurso A., Panza F. Short arm of chromosome 11 and sporadic Alzheimer's disease: catalase and cathepsin D gene polymorphisms. Neurosci. Lett. 2008, 432:237-242.
9. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Mastroianni F., Liaci M., Vendemiale G., Capurso A., Panza F. The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations. J. Gerontol. A: Biol. Sci. Med. Sci. 2005, 60:991-996.
10. Caracciolo B., Palmer K., Monastero R., Winblad B., Backman L., Fratiglioni L. Occurrence of cognitive impairment and dementia in the community. A 9-year-long prospective study. Neurology 2008.
11. Cataldo A.M., Barnett J.L., Berman S.A., Li J., Quarless S., Bursztajn S., Lippa C., Nixon R.A. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995, 14:671-680.
12. Chevallier N., Vizzavona J., Marambaud P., Baur C.P., Spillantini M., Fulcrand P., Martinez J., Goedert M., Vincent J.P., Checler F. Cathepsin D displays in vitro beta-secretase-like specificity. Brain Res. 1997, 750:11-19.
13. Coon K.D., Myers A.J., Craig D.W., Webster J.A., Pearson J.V., Lince D.H., Zismann V.L., Beach T.G., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Walker D.G., Ravid R., Heward C.B., Rogers J., Papassotiropoulos A., Reiman E.M., Hardy J., Stephan D.A. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J. Clin. Psychiatry 2007, 68:613-618.
14. Corder E.H., Huang R., Cathcart H.M., Lanham I.S., Parker G.R., Cheng D., Smith S., Poduslo S.E. Membership in genetic groups predicts Alzheimer disease. Rejuvenation Res. 2006, 9:89-93.
15. Crawford F.C., Freeman M.J., Schinka J., Abdullah L.I., Richards D., Sevush S., Duara R., Mullan M.J. The genetic association between Cathepsin D and Alzheimer's disease. Neurosci. Lett. 2000, 289:61-65.
16. Cummings J.L. Alzheimer's disease. N. Engl. J. Med. 2004, 351:56-67.
17. Davidson Y., Gibbons L., Pritchard A., Hardicre J., Wren J., Tian J., Shi J., Stopford C., Julien C., Thompson J., Payton A., Thaker U., Hayes A.J., Iwatsubo T., Pickering-Brown S.M., Pendleton N., Horan M.A., Burns A., Purandare N., Lendon C.L., Neary D., Snowden J.S., Mann D.M. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype. J. Neurol. Neurosurg. Psychiatry 2006, 77:515-517.
18. Emahazion T., Feuk L., Jobs M., Sawyer S.L., Fredman D., St Clair D., Prince J.A., Brookes A.J. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet. 2001, 17:407-413.
19. Ginsberg S.D., Hemby S.E., Lee V.M., Eberwine J.H., Trojanowski J.Q. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 2000, 48:77-87.
20. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
21. Hofman A., Breteler M.M., van Duijn C.M., Krestin G.P., Pols H.A., Stricker B.H., Tiemeier H., Uitterlinden A.G., Vingerling J.R., Witteman J.C. The Rotterdam Study: objectives and design update. Eur. J. Epidemiol. 2007, 22:819-829.
22. Ingegni T., Nocentini G., Mariani E., Spazzafumo L., Polidori M.C., Cherubini A., Catani M., Cadini D., Senin U., Mecocci P. Cathepsin D polymorphism in Italian elderly subjects with sporadic late-onset Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2003, 16:151-155.
23. Kenessey A., Nacharaju P., Ko L.W., Yen S.H. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J. Neurochem. 1997, 69:2026-2038.
24. Kolsch H., Ptok U., Majores M., Schmitz S., Rao M.L., Maier W., Heun R. Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease. Psychiatr. Genet. 2004, 14:97-100.
25. Ladror U.S., Snyder S.W., Wang G.T., Holzman T.F., Krafft G.A. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J. Biol. Chem. 1994, 269:18422-18428.
26. Li H., Wetten S., Li L., St Jean P.L., Upmanyu R., Surh L., Hosford D., Barnes M.R., Briley J.D., Borrie M., Coletta N., Delisle R., Dhalla D., Ehm M.G., Feldman H.H., Fornazzari L., Gauthier S., Goodgame N., Guzman D., Hammond S., Hollingworth P., Hsiung G.Y., Johnson J., Kelly D.D., Keren R., Kertesz A., King K.S., Lovestone S., Loy-English I., Matthews P.M., Owen M.J., Plumpton M., Pryse-Phillips W., Prinjha R.K., Richardson J.C., Saunders A., Slater A.J., St George-Hyslop P.H., Stinnett S.W., Swartz J.E., Taylor R.L., Wherrett J., Williams J., Yarnall D.P., Gibson R.A., Irizarry M.C., Middleton L.T., Roses A.D. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol. 2008, 65:45-53.
27. Mariani E., Seripa D., Ingegni T., Nocentini G., Mangialasche F., Ercolani S., Cherubini A., Metastasio A., Pilotto A., Senin U., Mecocci P. Interaction of CTSD and A2 M polymorphisms in the risk for Alzheimer's disease. J. Neurol. Sci. 2006, 247:187-191.
28. Mateo I., Sanchez-Guerra M., Combarros O., Llorca J., Infante J., Gonzalez-Garcia J., del Molino J.P., Berciano J. Lack of association between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish sample. Am. J. Med. Genet. 2002, 114:31-33.
29. Matsui T., Morikawa Y., Tojo M., Okamura N., Maruyama M., Hirai H., Chiba H., Matsushita S., Higuchi S., Arai H., Sasaki H. Cathepsin D polymorphism not associated with Alzheimer's disease in Japanese. Ann. Neurol. 2001, 49:544-545.
30. McIlroy S.P., Dynan K.B., McGleenon B.M., Lawson J.T., Passmore A.P. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease. Neurosci. Lett. 1999, 273:140-141.
31. Menzer G., Muller-Thomsen T., Meins W., Alberici A., Binetti G., Hock C., Nitsch R.M., Stoppe G., Reiss J., Finckh U. Non-replication of association between cathepsin D genotype and late onset Alzheimer disease. Am. J. Med. Genet. 2001, 105:179-182.
32. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
33. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
34. NIA-Working-Group Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiol. Aging 1997, 18:S1-S2.
35. Ntais C., Polycarpou A., Ioannidis J.P. Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. Am. J. Epidemiol. 2004, 159:527-536.
36. Ott A., Breteler M.M., van Harskamp F., Stijnen T., Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am. J. Epidemiol. 1998, 147:574-580.
37. Papassotiropoulos A., Bagli M., Feder O., Jessen F., Maier W., Rao M.L., Ludwig M., Schwab S.G., Heun R. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci. Lett. 1999, 262:171-174.
38. Papassotiropoulos A., Bagli M., Jessen F., Maier W., Forstl H., Kurz A., Heun R. Interaction of two genes possibly involved in the regulation of the amyloid precursor protein (APP) processing. Mol. Psychiatry 2000, 5:240-241.
39. Papassotiropoulos A., Bagli M., Kurz A., Kornhuber J., Forstl H., Maier W., Pauls J., Lautenschlager N., Heun R. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann. Neurol. 2000, 47:399-403.
40. Papassotiropoulos A., Lewis H.D., Bagli M., Jessen F., Ptok U., Schulte A., Shearman M.S., Heun R. Cerebrospinal fluid levels of beta-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D gene. Neuroreport 2002, 13:1291-1294.
41. Patterson C., Feightner J.W., Garcia A., Hsiung G.Y., MacKnight C., Sadovnick A.D. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. Cmaj 2008, 178:548-556.
42. Prince J.A., Feuk L., Sawyer S.L., Gottfries J., Ricksten A., Nagga K., Bogdanovic N., Blennow K., Brookes A.J. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur. J. Hum. Genet. 2001, 9:437-444.
43. Reiman E.M., Webster J.A., Myers A.J., Hardy J., Dunckley T., Zismann V.L., Joshipura K.D., Pearson J.V., Hu-Lince D., Huentelman M.J., Craig D.W., Coon K.D., Liang W.S., Herbert R.H., Beach T., Rohrer K.C., Zhao A.S., Leung D., Bryden L., Marlowe L., Kaleem M., Mastroeni D., Grover A., Heward C.B., Ravid R., Rogers J., Hutton M.L., Melquist S., Petersen R.C., Alexander G.E., Caselli R.J., Kukull W., Papassotiropoulos A., Stephan D.A. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007, 54:713-720.
44. Richards J.B., Rivadeneira F., Inouye M., Pastinen T.M., Soranzo N., Wilson S.G., Andrew T., Falchi M., Gwilliam R., Ahmadi K.R., Valdes A.M., Arp P., Whittaker P., Verlaan D.J., Jhamai M., Kumanduri V., Moorhouse M., van Meurs J.B., Hofman A., Pols H.A., Hart D., Zhai G., Kato B.S., Mullin B.H., Zhang F., Deloukas P., Uitterlinden A.G., Spector T.D. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008, 371:1505-1512.
45. Rogaeva E., Meng Y., Lee J.H., Gu Y., Kawarai T., Zou F., Katayama T., Baldwin C.T., Cheng R., Hasegawa H., Chen F., Shibata N., Lunetta K.L., Pardossi-Piquard R., Bohm C., Wakutani Y., Cupples L.A., Cuenco K.T., Green R.C., Pinessi L., Rainero I., Sorbi S., Bruni A., Duara R., Friedland R.P., Inzelberg R., Hampe W., Bujo H., Song Y.Q., Andersen O.M., Willnow T.E., Graff-Radford N., Petersen R.C., Dickson D., Der S.D., Fraser P.E., Schmitt-Ulms G., Younkin S., Mayeux R., Farrer L.A., St George-Hyslop P. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 2007, 39:168-177.
46. Sadik G., Kaji H., Takeda K., Yamagata F., Kameoka Y., Hashimoto K., Miyanaga K., Shinoda T. In vitro processing of amyloid precursor protein by cathepsin D. Int. J. Biochem. Cell. Biol. 1999, 31:1327-1337.
47. Saftig P., Peters C., von Figura K., Craessaerts K., Van Leuven F., De Strooper B. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J. Biol. Chem. 1996, 271:27241-27244.
48. Schwagerl A.L., Mohan P.S., Cataldo A.M., Vonsattel J.P., Kowall N.W., Nixon R.A. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J. Neurochem. 1995, 64:443-446.
49. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
50. Shacka J.J., Klocke B.J., Young C., Shibata M., Olney J.W., Uchiyama Y., Saftig P., Roth K.A. Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis. J. Neurosci. 2007, 27:2081-2090.
51. Sjogren M., Minthon L., Davidsson P., Granerus A.K., Clarberg A., Vanderstichele H., Vanmechelen E., Wallin A., Blennow K. CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging. J. Neural Transm. 2000, 107:563-579.
52. Slooter A.J., Cruts M., Kalmijn S., Hofman A., Breteler M.M., Van Broeckhoven C., van Duijn C.M. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch. Neurol. 1998, 55:964-968.
53. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:1977-1981.
54. Styczynska M., Religa D., Pfeffer A., Luczywek E., Wasiak B., Styczynski G., Peplonska B., Gabryelewicz T., Golebiowski M., Kobrys M., Barcikowska M. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci. Lett. 2003, 344:99-102.
55. The International HapMap Consortium, 2003. The International HapMap Project. Nature. 426, 789-796.
56. Waring S.C., Rosenberg R.N. Genome-wide association studies in Alzheimer disease. Arch. Neurol. 2008, 65:329-334.
57. Zaykin D.V., Zhivotovsky L.A. Ranks of genuine associations in whole-genome scans. Genetics 2005, 171:813-823.
58. Zhou W., Scott S.A., Shelton S.B., Crutcher K.A. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease. Neuroscience 2006, 143:689-701.